Breast Cancer Patients Without Pain Are at Risk for Skeletal-Related Events and May Have Better Outcomes with Zoledronic Acid Compared with Pamidronate.
AuthID
P-004-P8W
P-004-P8W
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service